Arcturus Therapeutics Holdings Inc.
ARCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768224
No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Arcturus Therapeutics Holdings Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 162 | 139 | −23 |
| Shares | 18.8M | 20.5M | +1.72M (+9.1%) |
| Value | $776.0M | $694.0M | −$82.0M (−10.6%) |
New holders (21)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (44)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q1 2021 and filed for Q2 2021 without it.